Eur Rev Med Pharmacol Sci 2021; 25 (6): 2460-2460
DOI: 10.26355/eurrev_202103_25398

LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway

Y. Lei, Y.-H. Wang, X.-F. Wang, J. Bai

Department of Medical Oncology, Shaanxi Provincial People’s Hospital, Xi’An, China.


The article “LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway, by Y. Lei, Y.-H. Wang, X.-F. Wang, J. Bai, published in Eur Rev Med Pharmacol Sci 2018; 22 (19): 6315-6323–DOI: 10.26355/eurrev_201810_16042–PMID: 30338799” has been withdrawn from the authors due to inaccuracies and mistakes throughout the paper.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/16042

Free PDF Download

To cite this article

Y. Lei, Y.-H. Wang, X.-F. Wang, J. Bai
LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 6
Pages: 2460-2460
DOI: 10.26355/eurrev_202103_25398